Minimizing Variations in Patient’s Experience with Levodopa Therapy in Parkinson's Disease

Robert Hauser, MD, MBA, discusses how the patient experience is defined in Parkinson disease.

Robert Hauser, MD, MBA, reviews the predictability of dyskinesia and OFF episodes in Parkinson disease.

Robert Hauser, MD, MBA, shares his expertise in the treatment of OFF time in Parkinson disease.

Robert Hauser, MD, MBA, talks about amantadine extended release for management of dyskinesia and OFF episodes.

Robert Hauser, MD, MBA, discussed unmet needs and future consideration in Parkinson disease.